The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker for Alzheimer’s. Previously, the only FDA-approved methods for detecting ...

The average future cost of long-term care for someone turning 65 today is about $122,400, the HHS-Urban report said. But some people need care for many years, pushing lifetime costs well into the ...

WASHINGTON (AP) — The World Pride 2025 welcome concert, with pop icon Shakira performing at Nationals Stadium, isn’t until ...

In 2023, the Food and Drug Administration (FDA) approved lecanemab, a new therapy for Alzheimer’s disease. This approval brought hope to many patients and doctors since lecanemab is the first drug of ...

The FDA-approved monoclonal antibody infusion known as donanemab, is showing promise to reduce cognitive decline among ...

The US on Friday approved the first blood test for Alzheimer's, a move that can help patients begin treatment earlier with ...

Joe Biden’s time in public office is now behind him, but his age and mental acuity have become a litmus test for the next ...

The United States on Friday approved the first blood test for Alzheimer’s, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the ...